Oscar Health reports Q1 2025 revenue of $3.05B, net income $275M, and reaffirms full-year guidance

Oscar Health, Inc.

2025-Q1 EPS reported $0.92 revenue$3,046,263,000

Total revenue rose 42% year-over-year to $3.046 billion for Q1 2025, driven by higher membership.
Net income attributable to Oscar Health grew to $275.3 million ($0.92 per diluted share) from $177.4 million.
Adjusted EBITDA increased to $328.8 million, up from $219.3 million in the prior-year quarter.
Membership reached 2,039,467 effectuated members, a 41% increase compared to Q1 2024.
Company reaffirms full-year 2025 outlook across all metrics as previously provided on February 4, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.